North Capital
ABBV icon

North Capital’s AbbVie ABBV Stock Holding History

North Capital’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$497K Sell
1,811
-109
-6% -$27.9K 0.35% 40
2026
Q2 		$483K Sell
1,920
-28
-1% -$6.02K 0.37% 41
2026
Q1 		$424K Hold
1,948
– – 0.36% 41
2025
Q4 		$445K Buy
1,948
+99
+5% +$22.6K 0.38% 39
2025
Q3 		$428K Buy
1,849
+188
+11% +$38.3K 0.33% 38
2025
Q2 		$308K Sell
1,661
-178
-10% -$33.1K 0.27% 52
2025
Q1 		$385K Buy
+1,839
New +$358K 0.36% 37

Other funds holding ABBV

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return
Asset Management One
Asset Management One Tokyo, Japan $40B AUM 30.45% 1-Year Est. Return
B. Metzler seel. Sohn & Co
B. Metzler seel. Sohn & Co Frankfurt, Germany $11.5B AUM 29.17% 1-Year Est. Return

North Capital's ABBV Position: Q3 2026 in Review

North Capital reduced its AbbVie (ABBV) stake by 5.7% in Q3 2026, selling an estimated $27.9K and leaving 1,811 shares worth $497K. The position accounts for 0.35% of the portfolio, ranked #40.

North Capital first reported a position in ABBV in Q1 2025 and has held it in 7 quarters since. 1,999 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • North Capital held 1,811 shares of AbbVie worth $497K as of Q3 2026.
  • North Capital sold 109 AbbVie shares in Q3 2026, an estimated $27.9K.
  • AbbVie made up 0.35% of North Capital's portfolio in Q3 2026, its #40 holding.
  • North Capital first reported a position in AbbVie in Q1 2025 and has held it in 7 quarters since.
  • 1,999 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on North Capital's 13F filing for Q3 2026, filed 16 Oct 2026.